To participate at the meeting online, go to www.virtualmeeting.co.nz/FPH22. You will require your shareholder number, found on your proxy form, for verification purposes.
Shareholders participating in the meeting online will be able to vote and ask questions. Members of the Board will answer as many of the questions as possible during the meeting. Instructions for online participation and voting can be found in the company’s Notice of Meeting located at www.fphcare.com/asm. Shareholders may also call the Link Market Services helpline on 0800 200 220 should they require assistance.
Shareholders wishing to join the meeting by telephone can dial 0800 449 170 in New Zealand and 1800 896 574 in Australia. For those outside of New Zealand or Australia, dial +64 800 449 170.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
GM Corporate Communications
+64 (0) 21 713 911
Investor Relations Manager
+64 (0) 27 807 8073
2022 Annual Shareholders’ Meeting Update
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment